Thursday, 25 February 2021

Agilent ties up with Cell Signaling technology

20 January 2015 | News | By BioSpectrum Bureau

Agilent ties up with Cell Signaling Technology

Financial details of the deal were not disclosed

Financial details of the deal were not disclosed

Dako Agilent Technologies and Cell Signaling Technology (CST) has announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products.

Agilent Diagnostics and genomics president Mr Jacob Thaysen said, "We are pleased that collaboration with the CST, and development partner of high quality, advanced diagnostic reagents products, these products will be an important tool for cancer diagnosis and treatment."

CST's chief executive, Mr Michael J Comb said, "CST recognizes that improving our methods of diagnosis and treatment of cancer patients, and companion diagnostic reagents products have great potential. We are confident that this partnership will allow our products to contribute to advances in personalized medicine."

Financial details of the deal were not disclosed.



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls